NMOSD
Clinical trials for NMOSD explained in plain language.
Never miss a new study
Get alerted when new NMOSD trials appear
Sign up with your email to follow new studies for NMOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial to find best drug for rare autoimmune disease
Disease control Not yet recruitingThis study compares five FDA-approved drugs (rituximab, ravulizumab, inebilizumab, satralizumab, and eculizumab) to see which works best to prevent relapses in people with NMOSD, a rare autoimmune condition that can cause vision loss and paralysis. About 160 adults who test posit…
Matched conditions: NMOSD
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 17, 2026 08:49 UTC
-
New antibody treatment could calm sudden attacks of rare nerve disorder
Disease control Not yet recruitingThis study tests whether monoclonal antibodies can safely reduce disability during sudden attacks of neuromyelitis optica spectrum disorder (NMOSD), a rare disease that inflames the nerves and eyes. Forty adults in the acute phase of NMOSD will receive the antibody treatment, and…
Matched conditions: NMOSD
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Hormone clues in rare brain disease
Knowledge-focused Not yet recruitingThis study looks at sex hormone levels in 4,000 people with NMOSD, a rare autoimmune disease affecting the nervous system. Researchers want to see if hormone changes are linked to the disease. Participants will provide blood samples for hormone testing. The goal is to better unde…
Matched conditions: NMOSD
Sponsor: Xiamen Hospital of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated May 05, 2026 11:56 UTC